Hall A, Abrahamson M, Grubb A, Trojnar J, Kania P, Kasprzykowska R, Kasprzykowski F
Department of Clinical Chemistry, University Hospital, Lund, Sweden.
J Enzyme Inhib. 1992;6(2):113-23. doi: 10.3109/14756369209040742.
The peptidyl diazomethanes Cbz-Gly-CHN2, Boc-Val-Gly-CHN2, H-Leu-Val-Gly-CHN2, Cbz-Leu-Val-Gly-CHN2 and Cbz-Arg-Leu-Val-Gly-CHN2, with peptidyl portions modelled after the proposed cysteine proteinase interacting N-terminal segment of human cystatin C, were synthesized. Their efficiency as cysteine proteinase inhibitors was tested against papain, human cathepsin B and bovine cathepsin B. All, except Cbz-Gly-CHN2, were found to be irreversible inhibitors of the tested enzymes. Each addition of an amino acid residue to their peptidyl portions resulted in an increased inhibition rate of all three enzymes. These data suggest that the arginyl residue of the tetrapeptidyl diazomethane, and also the corresponding arginyl residue in native cystatin C, interact with a S4 substrate pocket subsite of both papain and cathepsin B. The most efficient inhibitor, Cbz-Arg-Leu-Val-Gly-CHN2, inhibited papain and cathepsin B with rate constants of the same order of magnitude as those for L-3-carboxy-trans-2,3-epoxypropionyl-leucylamido-(4-guanidin o)butane (E-64). The high water-solubility of Cbz-Arg-Leu-Val-Gly-CHN2 allowing it to be dissolved to molar concentrations without use of non-physiological additives, makes it suitable for in vitro and in vivo cysteine proteinase inhibition studies.
合成了肽基重氮甲烷Cbz-Gly-CHN₂、Boc-Val-Gly-CHN₂、H-Leu-Val-Gly-CHN₂、Cbz-Leu-Val-Gly-CHN₂和Cbz-Arg-Leu-Val-Gly-CHN₂,其肽基部分是根据人胱抑素C中提议的与半胱氨酸蛋白酶相互作用的N端片段构建的。测试了它们作为半胱氨酸蛋白酶抑制剂对木瓜蛋白酶、人组织蛋白酶B和牛组织蛋白酶B的抑制效果。发现除Cbz-Gly-CHN₂外,其他所有化合物都是所测试酶的不可逆抑制剂。向其肽基部分每次添加一个氨基酸残基都会导致对所有三种酶的抑制率增加。这些数据表明,四肽基重氮甲烷的精氨酰残基以及天然胱抑素C中的相应精氨酰残基与木瓜蛋白酶和组织蛋白酶B的S4底物口袋亚位点相互作用。最有效的抑制剂Cbz-Arg-Leu-Val-Gly-CHN₂对木瓜蛋白酶和组织蛋白酶B的抑制速率常数与L-3-羧基-反式-2,3-环氧丙酰基-亮氨酰胺基-(4-胍基)丁烷(E-64)的抑制速率常数处于同一数量级。Cbz-Arg-Leu-Val-Gly-CHN₂具有高水溶性,无需使用非生理性添加剂即可溶解至摩尔浓度,这使其适用于体外和体内半胱氨酸蛋白酶抑制研究。